Abstract| Volume 18, ISSUE 6, SUPPLEMENT , S16, June 2016

Donor Age Impairs the Capacity of Human Mesenchymal Stromal Cells to Repair Cardiac and Renal Damage

      Introduction: In experimental models, the administration of mesenchymal stromal cells (MSC) reduces myocardial and renal damage, mainly through paracrine mechanisms. Thus, for translational purposes, it is essential to establish whether donor age influences the paracrine properties of human MSC. Accordingly, we aimed to compare the effects of conditioned medium (CM) derived from very young fetal MSC (F-CM) and with CM derived from adult bone marrow MSC (o-CM; age >65 years) in well-established experimental models of acute myocardial (AMI) and renal damage (AKI).
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Cytotherapy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect